Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Anders Kassow has worked on the following 12 EPO patent applications which have been published in the last five years:

EP11785367

CXCR2 BINDING POLYPEPTIDES

IPC classification:
C07K 16/28
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12768999

FUSION PROTEINS FOR TREATING METABOLIC DISORDERS

IPC classification:
A61K 47/48, C07K 14/50
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Daniela Gill-Carey, Novartis Pharmaceuticals UK Limited
Status:
GRANT OF PATENT INTENDED
EP13721396

TREATMENT OF FIBROSIS

IPC classification:
A61K 39/395, A61P 19/04
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13744818

ANTIBODY FORMULATION

IPC classification:
A61K 9/00, A61K 39/395, A61K 47/18, A61K 47/26, C07K 16/28
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13735529

BIOMARKERS ASSOCIATED WITH CDK INHIBITORS

IPC classification:
C12Q 1/68
Applicant:
Novartis AG
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Anders Kassow, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP11785007

METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

IPC classification:
C07K 14/50
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13812296

COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO

IPC classification:
A61K 39/00, C07K 16/22
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13815922

COMPOSITIONS AND METHODS THAT UTILIZE A PEPTIDE TAG THAT BINDS TO HYALURONAN

IPC classification:
C07K 14/47, C12N 15/62
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14713728

PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE

IPC classification:
A61K 38/18, C07K 14/475
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14714794

NOTCH2 BINDING MOLECULES FOR TREATING RESPIRATORY DISEASES

IPC classification:
C07K 16/28
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14710440

MARKERS FOR ISOCITRATE DEHYDROGENASE INHIBITORS

IPC classification:
C12Q 1/68
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP15731117

PULMONARY HYPERTENSION BIOMARKER

IPC classification:
C12Q 1/68, G01N 33/68
Applicant:
Novartis AG
Agent:
Anders Kassow, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature